⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IPSC News
Century Therapeutics, Inc. Common Stock
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
globenewswire.com
IPSC
Form 8-K
sec.gov
IPSC
Form 8-K
sec.gov
IPSC
Form 8-K
sec.gov
IPSC
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
globenewswire.com
IPSC
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company
prnewswire.com
GTBP
IPHA
INKT
IPSC
Form 8-K
sec.gov
CRBP
IPSC
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
globenewswire.com
IPSC
CRBP
Form 8-K
sec.gov
IPSC
Century Therapeutics Reports First Quarter Financial Results and Business Updates
globenewswire.com
IPSC